AR080733A1 - Aril-ciclohexil-tetraazabenzo[e]azulenos, un proceso para su obtencion, una composicion farmaceutica que los contiene y su uso para la preparacion de un medicamento para el tratamiento de enfermedades mediadas por el antagonismo del receptor de v1a - Google Patents
Aril-ciclohexil-tetraazabenzo[e]azulenos, un proceso para su obtencion, una composicion farmaceutica que los contiene y su uso para la preparacion de un medicamento para el tratamiento de enfermedades mediadas por el antagonismo del receptor de v1aInfo
- Publication number
- AR080733A1 AR080733A1 ARP110101019A ARP110101019A AR080733A1 AR 080733 A1 AR080733 A1 AR 080733A1 AR P110101019 A ARP110101019 A AR P110101019A AR P110101019 A ARP110101019 A AR P110101019A AR 080733 A1 AR080733 A1 AR 080733A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- halogen
- alkoxy
- group
- cyano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Estos compuestos actuan, como moduladores del receptor de V1a y en particular como antagonistas del receptor de V1a. Se reivindica además su obtencion, composiciones farmacéuticas que los contienen y su utilizacion como medicamentos. Los compuestos activos que se proveen en la presente solicitud son utiles como sustancias terapéuticas que actuan a nivel periférico y central en estados patologicos tales como la dismenorrea, disfuncion sexual masculina o femenina, hipertension, fallo cardíaco cronico, secrecion inapropiada de vasopresina, cirrosis hepática, síndrome nefrotico, ansiedad, trastornos depresivos, trastorno obsesivo-compulsivo, trastornos del espectro autista, esquizofrenia y conducta agresiva. Reivindicacion 1: Un compuesto de la formula (1) en la que R1 se elige entre el grupo formado por H, alquilo C1-6, sin sustituir o sustituido de 1 a 5 veces por sustituyentes elegidos individualmente entre el grupo formado por OH, halogeno, ciano y alcoxi C1-6, -(CH2)p-R4, p es el numero 0 o 1, R4 = fenilo o heteroarilo de 5 o 6 eslabones, cada uno de ellos está sin sustituir o sustituido de 1 a 5 veces por sustituyentes elegidos individualmente entre el grupo formado por OH, halogeno, ciano, alcoxi C1-6, halogeno-alquilo C1-6, halogeno-alcoxi C1-6 e hidroxi-alquilo C1-6, -S(O)2-alquilo C1-6, dicho alquilo C1-6 está sin sustituir o sustituido de 1 a 5 veces por sustituyentes elegidos individualmente entre el grupo formado por OH, halogeno, ciano y alcoxi C1-6, -C(O)-alquilo C1-6, dicho alquilo C1-6 está sin sustituir o sustituido de 1 a 5 veces por sustituyentes elegidos individualmente entre el grupo formado por OH, halogeno, ciano y alcoxi C1-6, y -C(O)O-alquilo C1-6, dicho alquilo C1-6 está sin sustituir o sustituido de 1 a 5 veces por sustituyentes elegidos individualmente entre el grupo formado por OH, halogeno, ciano y alcoxi C1-6; R2 se elige entre el grupo formado por hidrogeno y halogeno; R3 es arilo, sin sustituir o sustituido de 1 a 5 veces por sustituyentes elegidos individualmente entre el grupo formado por OH, halogeno, ciano, alquilo C1-6, alcoxi C1-6, halogeno- alquilo C1-6, halogeno-alcoxi C1-6 e hidroxi-alquilo C1-6 o una sal farmacéuticamente aceptable de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10158871 | 2010-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR080733A1 true AR080733A1 (es) | 2012-05-02 |
Family
ID=43858425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110101019A AR080733A1 (es) | 2010-03-31 | 2011-03-29 | Aril-ciclohexil-tetraazabenzo[e]azulenos, un proceso para su obtencion, una composicion farmaceutica que los contiene y su uso para la preparacion de un medicamento para el tratamiento de enfermedades mediadas por el antagonismo del receptor de v1a |
Country Status (14)
Country | Link |
---|---|
US (1) | US8420633B2 (es) |
EP (1) | EP2552919B1 (es) |
JP (1) | JP5599936B2 (es) |
KR (1) | KR101488073B1 (es) |
CN (1) | CN102822176B (es) |
AR (1) | AR080733A1 (es) |
BR (1) | BR112012024306A2 (es) |
CA (1) | CA2786657A1 (es) |
ES (1) | ES2523570T3 (es) |
HK (1) | HK1174613A1 (es) |
MX (1) | MX2012009941A (es) |
RU (1) | RU2566759C2 (es) |
TW (1) | TWI409264B (es) |
WO (1) | WO2011120877A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2356123T1 (sl) * | 2008-11-13 | 2013-01-31 | F. Hoffmann-La Roche Ag | Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni |
SG171742A1 (en) * | 2008-11-18 | 2011-07-28 | Hoffmann La Roche | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes |
EP2370441B1 (en) | 2008-11-28 | 2013-09-11 | F. Hoffmann-La Roche AG | Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin v1a receptor antagonists |
US8420633B2 (en) | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) * | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8513238B2 (en) | 2010-05-10 | 2013-08-20 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
CN104628555B (zh) * | 2015-01-05 | 2016-11-30 | 烟台蓓丰医药科技有限公司 | 一种药物中间体4-(4-氯苯基)环己基-1-甲酸的合成方法 |
JP6657611B2 (ja) * | 2015-06-15 | 2020-03-04 | Dic株式会社 | カルボニル化合物の製造方法 |
WO2017191117A1 (en) | 2016-05-03 | 2017-11-09 | Bayer Pharma Aktiengesellschaft | V1a receptor antagonists for use in the treatment of renal diseases |
EP4263544A1 (de) | 2020-12-18 | 2023-10-25 | Merck Patent GmbH | Indolo[3.2.1-jk]carbazole-6-carbonitril-derivate als blau fluoreszierende emitter zur verwendung in oleds |
TW202241905A (zh) | 2020-12-18 | 2022-11-01 | 德商麥克專利有限公司 | 用於有機電致發光裝置的氮化合物 |
WO2023161168A1 (de) | 2022-02-23 | 2023-08-31 | Merck Patent Gmbh | Aromatische heterocyclen für organische elektrolumineszenzvorrichtungen |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516774A (en) * | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
US5521173A (en) | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
WO1999006409A1 (en) * | 1997-07-30 | 1999-02-11 | American Home Products Corporation | Tricyclic vasopressin agonists |
HU229074B1 (en) | 1999-01-19 | 2013-07-29 | Ortho Mcneil Pharm Inc | Tricyclic benzodiazepines as vasopressin receptor antagonists |
US7109193B2 (en) * | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
PT1597260E (pt) * | 2003-02-19 | 2007-01-31 | Pfizer | Composto de triazole úteis em terapia |
GB0303852D0 (en) * | 2003-02-19 | 2003-03-26 | Pfizer Ltd | Triazole compounds useful in therapy |
GB0400700D0 (en) * | 2004-01-13 | 2004-02-18 | Pfizer Ltd | Compounds useful in therapy |
KR100840852B1 (ko) | 2004-05-25 | 2008-06-23 | 화이자 프로덕츠 인크. | 테트라아자벤조[e]아줄렌 유도체 및 이의 유사체 |
AP2006003768A0 (en) | 2004-05-25 | 2006-10-31 | Pfizer Prod Inc | TetraazabenzoÄeÜazulene derivatives and analogs tehereof |
GB0412874D0 (en) * | 2004-06-09 | 2004-07-14 | Pfizer Ltd | Novel pharmaceuticals |
EP1632494A1 (en) | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
MX2007002248A (es) | 2004-08-25 | 2008-10-02 | Pfizer | Triazolobenzodiazepinas y su uso como antagonistas de vasopresina. |
US20080188478A1 (en) | 2005-04-26 | 2008-08-07 | Pfizer Inc. | Compounds Useful In Therapy |
CA2608718A1 (en) | 2005-05-18 | 2006-11-23 | Pfizer Limited | 1, 2, 4-triazole derivatives as vasopressin antagonists |
KR101129791B1 (ko) | 2007-01-12 | 2012-03-23 | 에프. 호프만-라 로슈 아게 | 스파이로피페리딘 글리신아마이드 유도체 |
SG171742A1 (en) | 2008-11-18 | 2011-07-28 | Hoffmann La Roche | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes |
US8420633B2 (en) | 2010-03-31 | 2013-04-16 | Hoffmann-La Roche Inc. | Aryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8461151B2 (en) | 2010-04-13 | 2013-06-11 | Hoffmann-La Roche Inc. | Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes |
US8492376B2 (en) | 2010-04-21 | 2013-07-23 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8481528B2 (en) | 2010-04-26 | 2013-07-09 | Hoffmann-La Roche Inc. | Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
US8513238B2 (en) | 2010-05-10 | 2013-08-20 | Hoffmann-La Roche Inc. | Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes |
-
2011
- 2011-03-24 US US13/070,519 patent/US8420633B2/en not_active Expired - Fee Related
- 2011-03-25 CN CN201180015556.2A patent/CN102822176B/zh not_active Expired - Fee Related
- 2011-03-25 WO PCT/EP2011/054582 patent/WO2011120877A1/en active Application Filing
- 2011-03-25 RU RU2012144576/04A patent/RU2566759C2/ru not_active IP Right Cessation
- 2011-03-25 MX MX2012009941A patent/MX2012009941A/es active IP Right Grant
- 2011-03-25 CA CA2786657A patent/CA2786657A1/en not_active Abandoned
- 2011-03-25 KR KR1020127028482A patent/KR101488073B1/ko not_active IP Right Cessation
- 2011-03-25 JP JP2013501767A patent/JP5599936B2/ja not_active Expired - Fee Related
- 2011-03-25 BR BR112012024306A patent/BR112012024306A2/pt not_active IP Right Cessation
- 2011-03-25 EP EP11711074.2A patent/EP2552919B1/en not_active Not-in-force
- 2011-03-25 ES ES11711074.2T patent/ES2523570T3/es active Active
- 2011-03-29 AR ARP110101019A patent/AR080733A1/es unknown
- 2011-03-30 TW TW100111093A patent/TWI409264B/zh not_active IP Right Cessation
-
2013
- 2013-01-31 HK HK13101339.3A patent/HK1174613A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR112012024306A2 (pt) | 2016-05-24 |
RU2566759C2 (ru) | 2015-10-27 |
MX2012009941A (es) | 2012-09-21 |
JP5599936B2 (ja) | 2014-10-01 |
WO2011120877A1 (en) | 2011-10-06 |
CN102822176B (zh) | 2015-07-22 |
CN102822176A (zh) | 2012-12-12 |
HK1174613A1 (en) | 2013-06-14 |
TWI409264B (zh) | 2013-09-21 |
JP2013523675A (ja) | 2013-06-17 |
KR20130023228A (ko) | 2013-03-07 |
US20110245237A1 (en) | 2011-10-06 |
EP2552919B1 (en) | 2014-09-24 |
US8420633B2 (en) | 2013-04-16 |
ES2523570T3 (es) | 2014-11-27 |
EP2552919A1 (en) | 2013-02-06 |
CA2786657A1 (en) | 2011-10-06 |
TW201202243A (en) | 2012-01-16 |
KR101488073B1 (ko) | 2015-01-29 |
RU2012144576A (ru) | 2014-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR080733A1 (es) | Aril-ciclohexil-tetraazabenzo[e]azulenos, un proceso para su obtencion, una composicion farmaceutica que los contiene y su uso para la preparacion de un medicamento para el tratamiento de enfermedades mediadas por el antagonismo del receptor de v1a | |
AR080955A1 (es) | Aril-/heteroaril-ciclohexenil-tetraazabenzo(e)azulenos | |
AR081374A1 (es) | Heteroaril-ciclohexil-tetraazabenzo[e]azulenos | |
AR080927A1 (es) | Heteroaril-ciclohexil-tetraazabenzo[e]azulenos como antagonistas del receptor de v1a y un proceso para su obtencion | |
AR074409A1 (es) | Derivados de arilciclohexileteres de 5,6-dihidro-4h-2,3,5,10-b-tetraaza-benzo[e]azuleno, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos en disfunciones sexuales y trastornos del snc, entre otras patologias. | |
PH12018500106A1 (en) | Ethynyl derivatives as metabotropic glutamate receptor modulators | |
AR078756A1 (es) | Moduladores alostericos positivos (map) | |
AR074354A1 (es) | Alquilciclohexileteres de dihidrotetraazabenzoazulenos, procesos de preparacion y composiciones farmaceuticas que los contienen | |
CO6771446A2 (es) | Compuestos de bis(fluoroalquil)-1,4-benzodiazepinona | |
EA201490807A1 (ru) | Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1 | |
EA201591204A3 (ru) | Новые хиральные n-ацил-5,6,7,(8-замещенные)-тетрагидро-[1,2,4]триазоло[4,3-а]пиразины как селективные антагонисты рецептора nk-3, фармацевтическая композиция, способы применения при нарушениях, опосредованных nk-3 рецепторами, и их хиральный синтез | |
EA201390969A1 (ru) | Модуляторы глюкагонового рецептора | |
AR079260A1 (es) | Inhibidores de bencimidazol de la produccion de leucotrienos, un procedimiento para su preparacion, composiciones farmaceuticas que los comprenden y su empleo como medicamentos en el tratamiento de trastornos mediados por leucotrienos | |
MX2015017343A (es) | Derivados de pirrolopiridina o pirazolopiridina. | |
AR087915A1 (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1 | |
CO6612268A2 (es) | Heterobiaril-ciclohexil-tetraazabenzo[e]azulenos | |
ECSP11011196A (es) | Derivados de piperidina | |
EA201391124A1 (ru) | Новые бензодиоксолпиперазиновые соединения | |
RU2014117471A (ru) | ЦИКЛОГЕКСИЛ-4Н,6Н-5-ОКСА-2,3,10В-ТРИАЗАБЕНЗО[e]АЗУЛЕНЫ В КАЧЕСТВЕ АНТАГОНИСТОВ РЕЦЕПТОРА V1A | |
PH12014501943A1 (en) | Novel compounds for the treatment of dyslipidemia and related diseases | |
AR087999A1 (es) | Oxi-ciclohexil-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenos como antagonistas de la v1a | |
AR089087A1 (es) | Derivados del acido cicloalcanocarboxilico como antagonistas del receptor cxcr3 | |
EA201171010A1 (ru) | Производные 6-(6-o-циклоалкил- или 6-nh-циклоалкилтриазолопиридазинсульфанил)бензотиазолов и бензимидазолов: способ получения, применение в качестве лекарственных средств и применение в качестве ингибиторов met | |
CU20100124A7 (es) | 3-hidroxipiridinas sustituidas y composiciones farmacéuticas de las mismas | |
TH151337A (th) | มอดูเลเตอร์แบบอัลโลสเตอริกชนิดโพซิทีฟ (pam) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |